Circulating Cell-Free Mitochondrial DNA: A Potential Blood-Based Biomarker for Sarcopenia in Patients Undergoing

Zhen Fan1, Yi Guo2, Xiao-Yi Zhong3

  • 1Department of Geriatrics, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, China (mainland).

Insights

Cell-free mitochondrial DNA (cf-mtDNA) is elevated in hemodialysis patients with sarcopenia, suggesting it may drive inflammation and contribute to muscle loss in this population.

Area of Science:

  • Mitochondrial Biology
  • Immunology
  • Geriatrics

Background:

  • Sarcopenia, characterized by muscle loss, is linked to mitochondrial dysfunction and inflammation.
  • Cell-free mitochondrial DNA (cf-mtDNA) is implicated as a pro-inflammatory molecule.
  • The role of cf-mtDNA in sarcopenia, particularly in maintenance hemodialysis (MHD) patients, requires further investigation.

Purpose of the Study:

  • To investigate the association between circulating cell-free mitochondrial DNA (ccf-mtDNA) and sarcopenia in MHD patients.
  • To explore the relationship between cf-mtDNA, inflammation, and mitophagy in peripheral blood mononuclear cells (PBMCs) of MHD patients.

Main Methods:

  • 105 MHD patients were categorized into sarcopenia (SP) and non-sarcopenia (NSP) groups.
  • Quantified ccf-mtDNA using TaqMan RT-qPCR.
  • Assessed cytosolic mtDNA, inflammation (TLR9, IL-6), and mitophagy (Parkin, LAMP2) gene expression in PBMCs via SYBR Green RT-qPCR.
  • Measured mitochondrial membrane potential (ΔΨm) using JC-1.

Main Results:

  • ccf-mtDNA levels were significantly higher in the SP group compared to the NSP group.
  • Multivariate analysis confirmed a correlation between ccf-mtDNA and sarcopenia, independent of confounders.
  • SP patients exhibited increased cytosolic mtDNA and elevated TLR9 and IL-6 expression in PBMCs.
  • Reduced ΔΨm and increased mitophagy gene expression (Parkin, LAMP2) were observed in PBMCs from SP patients.

Conclusions:

  • Elevated ccf-mtDNA is associated with sarcopenia in MHD patients.
  • ccf-mtDNA may act as a pro-inflammatory factor contributing to the pathogenesis of sarcopenia in MHD.
  • Mitochondrial dysfunction and altered mitophagy pathways are implicated in MHD-related sarcopenia.

Related Concept Videos